Skip to content

Schilke Tobin

Reporting owner on Forms 3, 4 and 5, CIK 1678984.

Schilke Tobin reported on 1 issuer in 2 filings, the latest a Form 4 filed 2026-11-17.

Issuers

IssuerRoles in the latest filingFilingsLast filed
Lexeo Therapeutics, Inc. CIK 1907108director12026-11-17

Transactions and holdings

Every row of the person's Forms 3, 4 and 5, newest first, with the price and the amount owned after the row as filed.

SecurityDateCodeSharesPriceOwned afterFiling
LXEO · Lexeo Therapeutics, Inc.Stock Option (right to buy), derivative2026-11-14A granted+70,000$070,000Form 4

Filings

The person's Forms 3, 4 and 5, and any 13D or 13G naming it.

FilingSubjectFiledAcceptedIngested
Form 4 0001678984-26-000005 Lexeo Therapeutics, Inc.2026-11-17
Form 3 0001678984-26-000004 Lexeo Therapeutics, Inc.2026-11-17